Semaglutide and tirzepatide are both GLP-1 receptor agonist medications initially developed for diabetes management. However, clinical trials showed they also have significant efficacy for weight loss goals.
These injectables help patients achieve weight loss goals by:
- Enhancing insulin secretion to make you less hungry
- Delaying gastric emptying for a longer sated feeling
- Reducing cravings